• PtrbZIP12 Controls Drought Resistance via Phosphorylation in

  2026-07-01

  This study uncovers how the bZIP transcription factor PtrbZIP12 enhances drought resistance in Populus trichocarpa by directly activating PtrDHN and PtrPOD, with phosphorylation acting as a key regulatory mechanism. These findings clarify the molecular basis of drought adaptation and provide new directions for dissecting phosphorylation-dependent stress responses in plants.

• Cannabidiol Modulates Orofacial Inflammatory Pain and Affect

  2026-06-30

  This study elucidates how cannabidiol (CBD) attenuates both sensory and emotional aspects of orofacial inflammatory pain in mice, acting through coordinated endocannabinoid and serotonergic mechanisms. The comprehensive experimental approach highlights CBD’s potential to address multidimensional pain and its affective comorbidities, with implications for translational pain management research.

• Ciprofloxacin in Antimicrobial Resistance Research Workflows

  2026-06-30

  Ciprofloxacin, a benchmark fluoroquinolone antibiotic, is pivotal for dissecting DNA replication inhibition and resistance gene transmission in laboratory models. This article details actionable protocols and troubleshooting strategies, leveraging recent breakthroughs to empower robust antimicrobial resistance research.

• D-Luciferin: Precision Firefly Luciferase Substrate for Biol

  2026-06-29

  D-Luciferin is a high-affinity, membrane-permeable substrate for firefly luciferase, enabling sensitive quantification of intracellular ATP and non-invasive bioluminescence imaging. This article details its biochemical rationale, mechanism, and validated research applications.

• Cannabidiol Attenuates Orofacial Pain via Cannabinoid-Seroto

  2026-06-29

  This study demonstrates that cannabidiol (CBD) robustly reduces both sensory and affective dimensions of orofacial inflammatory pain in mice. Mechanistically, CBD achieves these effects through coordinated modulation of endocannabinoid and serotonergic pathways, highlighting its translational potential for treating complex pain conditions with emotional comorbidities.

• Agatoxin-IVA-Sensitive Calcium Channels in Cardiac Vagal Neu

  2026-06-28

  This study identifies P-type (agatoxin-IVA-sensitive) calcium channels as key mediators of both presynaptic and postsynaptic nicotinic activation in cardiac vagal neurons. The findings clarify the specific voltage-dependent calcium channel subtypes involved in neurocardiac regulation, with implications for precise modulation of autonomic function.

• Fluconazole (SKU B2094) in Antifungal Assays: Protocols & Pr

  2026-06-27

  This article addresses common laboratory challenges in antifungal susceptibility testing and drug resistance research, emphasizing evidence-driven best practices with Fluconazole (SKU B2094) as a fungal cytochrome P450 enzyme 14α-demethylase inhibitor. Scenario-based Q&A blocks provide practical guidance for experimental design, data interpretation, and vendor selection, ensuring biomedical researchers access reproducible, high-quality results with APExBIO’s Fluconazole.

• PEGylation Improves Stability and Targeting of LAF–Xenopepti

  2026-06-26

  This study demonstrates that PEGylation of LAF–xenopeptide mRNA polyplexes increases colloidal stability and enables efficient ligand-mediated targeting in mammalian systems. The findings highlight how rational PEG-lipid incorporation balances transfection efficiency and biosafety, with implications for advancing non-viral mRNA delivery technologies.

• EZ Cap™ Cas9 mRNA (5-moUTP): Precision Genome Editing for Ne

  2026-06-26

  Explore how EZ Cap™ Cas9 mRNA (5-moUTP) empowers researchers to dissect neuroinflammatory pathways with unprecedented precision. This article reveals advanced protocol guidance and unique scientific insights for functional gene editing in complex CNS models.

• Immune Cell Rejuvenation Mitigates Alzheimer’s Pathology in

  2026-06-25

  Sun et al. demonstrate that rejuvenating peripheral immune cells via young bone marrow transplantation reduces amyloid pathology and cognitive deficits in a murine Alzheimer’s model. Their single-cell transcriptomic analysis reveals systemic shifts in immune cell gene expression, supporting the immune system as a promising target for Alzheimer’s intervention.

• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode Tracking and T

  2026-06-25

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) empowers researchers with simultaneous fluorescence and bioluminescence detection for real-time mRNA delivery, intracellular trafficking, and translation efficiency studies. Its Cap1 capping, 5-moUTP modification, and Cy5 labeling collectively enable robust, immune-evasive expression and precise quantitation, setting a new benchmark for advanced mRNA workflows.

• LLY507: Decoding SMYD2 Inhibition for Cancer and Renal Fibro

  2026-06-24

  Explore how LLY507, a potent SMYD2 inhibitor, enables precise cancer cell proliferation inhibition and fibrosis research. This article provides an advanced analysis of SMYD2 targeting, unique mechanistic insights, and practical guidance for translational assays.

• Lipidomics Reveals Ginsenoside F1 Mitigates FFA-Induced Lipi

  2026-06-23

  This study applies lipidomics to elucidate how ginsenoside F1 alleviates free fatty acid-induced lipid metabolic disturbances in HepG2 cells, highlighting its modulation of glycerophospholipid and ether lipid pathways. The findings suggest new molecular targets and approaches in hyperlipidemia research, with implications for comparative statin studies.

• BIIE 0246: Reliable Y2R Antagonism for Adipose-Neural Axis R

  2026-06-23

  This article examines how BIIE 0246 (SKU B6836), a potent neuropeptide Y Y2 receptor antagonist, addresses common laboratory challenges in adipose-neural axis and cardiac arrhythmia studies. With scenario-driven guidance and data-backed protocol parameters, researchers gain practical insight into optimizing cell-based assays and interpreting NPY Y2 receptor inhibition using BIIE 0246.

• EZ Cap™ Firefly Luciferase mRNA (5-moUTP): Unveiling Mechani

  2026-06-22

  Explore how Firefly Luciferase mRNA with 5-moUTP modification advances translational research by combining robust bioluminescent reporting with enhanced mRNA stability and minimal immune activation. This article uniquely integrates recent LNP delivery insights to optimize assay design and mRNA delivery strategies.

640 records 10/43 page Previous Next First page 上5页 678910 下5页 Last page